Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors
Article in European Journal of Pharmacology (March 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (March 2024)
Article in The Lancet Haematology (May 2022)
Article in Leukemia Research (February 2022)